AstraZeneca’s Covishield causes rare blood clot-disorder TTS, admits Covid vaccine’s side effect

Astrazeneca’s Covishield Causes Rare Blood Clot Disorder Tts, Admits Covid Vaccine’s Side Effect

In a legal document submitted before the High Court of Justice, London, UK pharmaceutical giant AstraZeneca has admitted that its Covid vaccine, Covishield, ‘can, in very rare cases, cause TTS’ – Thrombosis with Thrombocytopenia Syndrome, a clotting disorder


Discover more from The Doon Mozaic

Subscribe to get the latest posts to your email.

Leave a Reply

Your email address will not be published. Required fields are marked *

Discover more from The Doon Mozaic

Subscribe now to keep reading and get access to the full archive.

Continue reading